Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Integrative multi-omics identifies a glycosylation-based prognostic framework and nominates ALG3 for targeted therapy in bladder cancer
Saved in:
| Published in: | Discover Oncology |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1868553801117466625 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | Discover Oncology |
| description | |
| discipline_display | Endocrinology |
| discipline_facet | Endocrinology |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:88613 |
| institution | FRELIP |
| journal_source_facet | Discover Oncology |
| last_indexed | 2026-06-20T21:42:46.854Z |
| publishDate | 2026 |
| publishDateSort | 2026 |
| record_format | rss_article |
| spellingShingle | Integrative multi-omics identifies a glycosylation-based prognostic framework and nominates ALG3 for targeted therapy in bladder cancer Endocrinology General Endocrinology |
| sub_discipline_display | General |
| sub_discipline_facet | General |
| subject_display | Endocrinology General Endocrinology |
| subject_facet | Endocrinology General Endocrinology |
| title | Integrative multi-omics identifies a glycosylation-based prognostic framework and nominates ALG3 for targeted therapy in bladder cancer |
| title_alt | Multiómica integrativa identifica un marco pronóstico basado en glicosilación y nomina a ALG3 para terapia dirigida en cáncer de vejiga Multi-omique intégrative identifie un cadre pronostique basé sur la glycosylation et désigne ALG3 pour une thérapie ciblée dans le cancer de la vessie Multi-ômica Integrativa Identifica um Quadro Prognóstico Baseado em Glicosilação e Nomeia ALG3 para Terapia Alvo no Câncer de Bexiga |
| title_auth | Integrative multi-omics identifies a glycosylation-based prognostic framework and nominates ALG3 for targeted therapy in bladder cancer |
| title_es_txt | Multiómica integrativa identifica un marco pronóstico basado en glicosilación y nomina a ALG3 para terapia dirigida en cáncer de vejiga |
| title_fr_txt | Multi-omique intégrative identifie un cadre pronostique basé sur la glycosylation et désigne ALG3 pour une thérapie ciblée dans le cancer de la vessie |
| title_full | Integrative multi-omics identifies a glycosylation-based prognostic framework and nominates ALG3 for targeted therapy in bladder cancer |
| title_fullStr | Integrative multi-omics identifies a glycosylation-based prognostic framework and nominates ALG3 for targeted therapy in bladder cancer |
| title_full_unstemmed | Integrative multi-omics identifies a glycosylation-based prognostic framework and nominates ALG3 for targeted therapy in bladder cancer |
| title_pt_txt | Multi-ômica Integrativa Identifica um Quadro Prognóstico Baseado em Glicosilação e Nomeia ALG3 para Terapia Alvo no Câncer de Bexiga |
| title_short | Integrative multi-omics identifies a glycosylation-based prognostic framework and nominates ALG3 for targeted therapy in bladder cancer |
| title_sort | integrative multi-omics identifies a glycosylation-based prognostic framework and nominates alg3 for targeted therapy in bladder cancer |
| topic | Endocrinology General Endocrinology |
| url | https://link.springer.com/article/10.1007/s12672-026-05387-1 |